A Novel ANG-BSA/BCNU/ICG MNPs Integrated for Targeting Therapy of Glioblastoma

Purpose Develop an albumin nanoparticle-based nanoprobe for targeted glioblastoma (GBM) diagnosis and treatment, utilizing Angopep-2 for low-density lipoprotein receptor-related protein (LRP) targeting. Methods Combined albumin-coated superparamagnetic iron oxide (SPIO), Carmustine (BCNU), and indoc...

Full description

Saved in:
Bibliographic Details
Main Authors: Li-Hong Liu BS, Yu-Feng Liu MD, Hong-Bo Zhang MD, PhD, Xiao-Lei Liu BS, Han-Wen Zhang MD, PhD, Biao Huang MD, PhD, Fan Lin MD, PhD, Wei-Hua Li MD, PhD
Format: Article
Language:English
Published: SAGE Publishing 2024-10-01
Series:Technology in Cancer Research & Treatment
Online Access:https://doi.org/10.1177/15330338241281321
Tags: Add Tag
No Tags, Be the first to tag this record!